An update from Petros Pharmaceuticals ( (PTPI) ) is now available.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Petros Pharmaceuticals has amended its employment agreement with President Fady Boctor, allowing him to engage in other consulting roles, provided no conflicts arise. The amendment also adjusts his salary to $280,000 annually and sets the employment term to end on December 31, 2024. This move could signal strategic adjustments within the company’s leadership structure.
Find detailed analytics on PTPI stock on TipRanks’ Stock Analysis page.
